Want to see SE:STIL full AI Analyst Report?
Stille AB (STIL) Price & Analysis
STIL Stock Chart & Stats
- Day’s Range
- SEK 245.00 - SEK 250.50
- 52-Week Range
- SEK 143.00 - SEK 283.00
- Previous Close
- SEK 250.00
- Volume
- 3,081
- Average Volume (3M)
- 12.43K
- Market Cap
- SEK 2.23B
- Enterprise Value
- SEK 2.05B
- Total Cash (Recent Filing)
- SEK 170.71M
- Total Debt (Recent Filing)
- SEK 0
- Price to Earnings (P/E)
- 23.2
- Beta
- 0.27
- Next Earnings
- Feb 12, 2027
- EPS Estimate
- 3.01
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability Growth
Strong organic growth is being accompanied by faster EBITDA expansion, indicating operating leverage rather than growth purchased solely through higher costs. If sustained, this combination can strengthen earnings power, fund commercial investment, and support continued competitive progress over the next several quarters.
Debt-Free Balance Sheet And Cash Generation
The net cash position and high equity-to-assets ratio provide substantial financial flexibility for investment, acquisitions, and resilience through demand fluctuations. Stronger operating cash flow also improves the quality of reported earnings and reduces reliance on external financing for future growth.
Market Share And Product Positioning
Taking share in a market supported by care-setting investments suggests Stille's products and commercial capabilities are gaining relevance beyond temporary demand effects. The imagiQ3 portfolio, direct teams, and partners can reinforce customer access and create a platform for durable expansion.
Bears Say
Backorders And Supply Normalization
Persistently elevated backorders can delay customer deliveries, defer revenue recognition, and constrain the company's ability to convert strong underlying demand into repeatable sales. Continued investment may improve service, but normalization remains necessary for execution and customer experience.
Currency Pressure On Instrument Margins
Currency pressure is already reducing reported profitability in the Surgical Instruments business, limiting the benefit of strong sales growth. If exchange-rate effects persist, they could keep margins below potential and make earnings progression less predictable despite stable underlying segment performance.
Surgical Tables Growth Normalization
The unusually strong Surgical Tables growth rate is not a dependable baseline for future periods because management says the broader market is not expanding at 30%. A normalization in this segment could slow group growth and reduce operating leverage after the current surge.
Stille AB News
STIL FAQ
What was Stille AB’s price range in the past 12 months?
What is Stille AB’s market cap?
When is Stille AB’s upcoming earnings report date?
How were Stille AB’s earnings last quarter?
Is Stille AB overvalued?
Does Stille AB pay dividends?
What is Stille AB’s EPS estimate?
How many shares outstanding does Stille AB have?
What happened to Stille AB’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Stille AB?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, and S&T brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular procedures under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB was founded in 1841 and is headquartered in Torshälla, Sweden.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- Ulrik Berthelsen
- Employees
- 225
- Website
- www.stille.se
- Address
- Ekbacken 11, Torshälla, SD, 644 30, SE
Stille AB (STIL) Earnings & Revenues
STIL Earnings Call
Earnings Call SentimentPositive
The call was strongly positive, with record rolling 12-month sales, robust organic growth, improved margins, sharply higher operating cash flow, stronger delivery performance, and a net cash position. The main challenges were elevated backorders, currency-related pressure on Surgical Instruments margins, partially outstanding tariff refunds, and management's caution that the exceptional 30% Surgical Tables growth rate is not expected to continue at the same level.
View all SE:STIL earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 6 | 0 | 6 |

